Preliminary studies showed that copper (Cu) deficiency in the rat significantly enhanced: i) antiinflammatory activity of aspirin and cortisol; ii) hypnotic activity of pentobarbital; and iii) cocaine-induced seizures and mortality. A review of the literature revealed only few articles where such effects were reported. Several reports, however, did indicate INDIRECTLY that such alterations were indeed likely. Nevertheless, it was clear that among many types of interactions that can alter the activity of a drug, this type of drug-nutritional state interaction has not been well studies. We, therefore, propose to study it with respect to Cu deficiency. These studies may shed some light, for example, on the observed wide variation in susceptibility of humans to cocaine- induced arrhythmias and death, and may illustrate the importance of the assessment of nutritional status with respect to minerals especially during therapy with agents with a narrow therapeutic window. The overall aim of this proposal is to study the pharmacodynamic, pharmacokinetic, and metabolic basis for the effects of Cu deficiency on aspirin, cortisol, and cocaine activities in the Cu- deficient (CUD) rat by: i) comparing the antiinflammatory activity of aspirin in CUD and Cu-sufficient (CUS) rats at 4 stages of Cu deficiency, ii) comparing the analgesic activity of aspirin in CUD and CUS rats; iii) studying the reversibility of the effects of Cu deficiency on aspirin; iv) by comparing dose response curves of aspirin, cortisol, and cocaine in CUD and CUS rats; v) comparing pharmacokinetics and hepatic metabolism of aspirin, cortisol, and cocaine in CUD and CUS rats; and by vi) correlating various effects of Cu deficiency with changes in the degree of Cu deficiency and formulating a hypothesis for the mechanism by which Cu deficiency exerts its effects. Our long term goal is to study the significance of mineral deficiencies in altering the activity of drugs with a narrow therapeutic window because it is with these drugs that minor changes in activity may lead to major undesirable consequences.

Project Start
Project End
Budget Start
Budget End
Support Year
21
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Xavier University of Louisiana
Department
Type
DUNS #
020857876
City
New Orleans
State
LA
Country
United States
Zip Code
70125
Shimada, Tsutomu; Takenaka, Shigeo; Kakimoto, Kensaku et al. (2016) Structure-Function Studies of Naphthalene, Phenanthrene, Biphenyl, and Their Derivatives in Interaction with and Oxidation by Cytochromes P450 2A13 and 2A6. Chem Res Toxicol 29:1029-40
Shimada, Tsutomu; Takenaka, Shigeo; Murayama, Norie et al. (2016) Oxidation of pyrene, 1-hydroxypyrene, 1-nitropyrene and 1-acetylpyrene by human cytochrome P450 2A13. Xenobiotica 46:211-24
Liu, Jiawang; Pham, Peter T; Skripnikova, Elena V et al. (2015) A Ligand-Based Drug Design. Discovery of 4-Trifluoromethyl-7,8-pyranocoumarin as a Selective Inhibitor of Human Cytochrome P450 1A2. J Med Chem 58:6481-93
Goyal, Navneet; Liu, Jiawang; Lovings, La'Nese et al. (2014) Ethynylflavones, highly potent, and selective inhibitors of cytochrome P450 1A1. Chem Res Toxicol 27:1431-9
Liu, Jiawang; Taylor, Shannon F; Dupart, Patrick S et al. (2013) Pyranoflavones: a group of small-molecule probes for exploring the active site cavities of cytochrome P450 enzymes 1A1, 1A2, and 1B1. J Med Chem 56:4082-92
Foroozesh, Maryam; Jiang, Quan; Sridhar, Jayalakshmi et al. (2013) DESIGN, SYNTHESIS, AND EVALUATION OF CARBAZOLE ANALOGS AS POTENTIAL CYTOCHROME P450 INHIBITORS. J Undergrad Chem Res 12:92-95
Foroozesh, Maryam; Jiang, Quan; Sridhar, Jayalakshmi et al. (2013) DESIGN, SYNTHESIS, AND EVALUATION OF A FAMILY OF PROPARGYL PYRIDINYL ETHERS AS POTENTIAL CYTOCHROME P450 INHIBITORS. J Undergrad Chem Res 12:91-94
Shimada, Tsutomu; Kim, Donghak; Murayama, Norie et al. (2013) Binding of diverse environmental chemicals with human cytochromes P450 2A13, 2A6, and 1B1 and enzyme inhibition. Chem Res Toxicol 26:517-28
Liu, Jiawang; Sridhar, Jayalakshmi; Foroozesh, Maryam (2013) Cytochrome P450 family 1 inhibitors and structure-activity relationships. Molecules 18:14470-95
Liu, Jiawang; Nguyen, Thong T; Dupart, Patrick S et al. (2012) 7-Ethynylcoumarins: selective inhibitors of human cytochrome P450s 1A1 and 1A2. Chem Res Toxicol 25:1047-57

Showing the most recent 10 out of 34 publications